These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 32843547)

  • 1. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
    Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional
    Park A; Oh S; Jung KL; Choi UY; Lee HR; Rosenfeld MG; Jung JU
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21618-21627. PubMed ID: 32817485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction.
    Bi X; Yang L; Mancl ME; Barnes BJ
    J Interferon Cytokine Res; 2011 Apr; 31(4):373-82. PubMed ID: 21133648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
    Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
    J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
    Paul AG; Chandran B; Sharma-Walia N
    Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.
    Zhang YJ; Patel D; Nan Y; Fan S
    Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.
    Landis JT; Tuck R; Pan Y; Mosso CN; Eason AB; Moorad R; Marron JS; Dittmer DP
    mBio; 2022 Feb; 13(1):e0347321. PubMed ID: 35089062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication.
    Lee HR; Doğanay S; Chung B; Toth Z; Brulois K; Lee S; Kanketayeva Z; Feng P; Ha T; Jung JU
    J Virol; 2014 Feb; 88(4):2183-94. PubMed ID: 24335298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival.
    Wang C; Zhu C; Wei F; Zhang L; Mo X; Feng Y; Xu J; Yuan Z; Robertson E; Cai Q
    J Virol; 2015 Oct; 89(20):10416-26. PubMed ID: 26246572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
    Nakayama R; Ueno Y; Ueda K; Honda T
    Oncogene; 2019 May; 38(22):4340-4351. PubMed ID: 30770900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
    Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KSHV vIRF4 enhances BCL6 transcription via downregulation of IRF4 expression.
    Yu HR; Kim YJ; Lee HR
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1128-1133. PubMed ID: 29397940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors.
    Wang C; Zhang L; Ke L; Ding W; Jiang S; Li D; Narita Y; Hou I; Liang J; Li S; Xiao H; Gottwein E; Kaye KM; Teng M; Zhao B
    Nat Commun; 2020 Dec; 11(1):6318. PubMed ID: 33298918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Druggable host gene dependencies in primary effusion lymphoma.
    Kuehnle N; Gottwein E
    Curr Opin Virol; 2022 Oct; 56():101270. PubMed ID: 36182745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. vIRF3 encoded by Kaposi's sarcoma-associated herpesvirus inhibits T-cell factor-dependent transcription via a CREB-binding protein-interaction motif.
    Cha S; Choe J; Seo T
    Biochem Biophys Res Commun; 2016 Oct; 479(4):697-702. PubMed ID: 27693583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
    Jiang Y; Xu D; Zhao Y; Zhang L
    PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.